Ignite Creation Date:
2024-05-05 @ 11:12 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01276522
Status:
COMPLETED
Last Update Posted:
2012-05-24
First Post:
2011-01-12
Brief Title:
Efficacy and Safety of Canakinumab in Schnitzler Syndrome
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Organization Data
Organization:
Radboud University Medical Center
Class:
OTHER
Study ID:
2010-SS-Canakinumab
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Radboud University Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |